Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study).
Buljubasic N, Vroegindewey MM, Oemrawsingh RM, Asselbergs FW, Cramer E, Liem A, van der Harst P, Maas A, Ronner E, Schotborgh C, Wardeh AJ, Akkerhuis KM, Boersma E; BIOMArCS investigators. Buljubasic N, et al. Among authors: oemrawsingh rm. Am J Cardiol. 2019 Jul 1;124(1):8-13. doi: 10.1016/j.amjcard.2019.03.049. Epub 2019 Apr 18. Am J Cardiol. 2019. PMID: 31047655 Free article.
Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
Landmesser U, Ali ZA, Maehara A, Matsumura M, Shlofmitz RA, Guagliumi G, Price MJ, Hill JM, Akasaka T, Prati F, Bezerra HG, Wijns W, Leistner D, Canova P, Alfonso F, Fabbiocchi F, Calligaris G, Oemrawsingh RM, Achenbach S, Trani C, Singh B, McGreevy RJ, McNutt RW, Ying SW, Buccola J, Stone GW. Landmesser U, et al. Among authors: oemrawsingh rm. Eur Heart J. 2024 Nov 14;45(43):4630-4643. doi: 10.1093/eurheartj/ehae521. Eur Heart J. 2024. PMID: 39196989 Free PMC article. Clinical Trial.
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience.
Ninomiya K, Serruys PW, Garg S, Hara H, Masuda S, Kageyama S, Kotoku N, Sevestre E, Kumar A, O'Kane P, Zaman A, Farah B, Magro M, Oemrawsingh RM, Möllmann H, Meneveau N, Achenbach S, Lemoine J, Allali A, Gallagher S, Wykrzykowska J, Lesiak M, Silvestri M, Wijns W, Sharif F, Onuma Y. Ninomiya K, et al. Among authors: oemrawsingh rm. Rev Cardiovasc Med. 2022 Apr 8;23(4):133. doi: 10.31083/j.rcm2304133. eCollection 2022 Apr. Rev Cardiovasc Med. 2022. PMID: 39076220 Free PMC article.
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
Oemrawsingh RM, Lenderink T, Akkerhuis KM, Heeschen C, Baldus S, Fichtlscherer S, Hamm CW, Simoons ML, Boersma E; CAPTURE investigators. Oemrawsingh RM, et al. Heart. 2011 Jul;97(13):1061-6. doi: 10.1136/hrt.2010.197392. Epub 2011 May 10. Heart. 2011. PMID: 21558475
82 results